Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Fludrocortisone in Septic Shock
NCT07451886Phase 2Recruiting
- Sponsor
- The Chinese University of Hong Kong
- Start
- Apr 2026
- Primary completion
- Jul 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in septic shock comparing Fludrocortisone with Placebo (2 arms). Primary endpoints: Number of Protocol deviations < 15% at 20 months, Number of Lost of concealment < 10% at 20 months and 2 more. Started Apr 2026; status: recruiting.
02
Drugs
fludrocortisone
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT07451886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07451886.